Use of advanced systemic therapy in adolescent patients with moderate-to-severe atopic dermatitis in the TARGET-DERM Registry

Main Article Content

Michael Haft
Keith Knapp
Ami Claxton
Breda Munoz
Sanjeev Balu
Shannon Schnieder
Jonathan Silverberg
Diamant Thaci
Lawrence Eichenfield


Advanced Systemic Therapy, Adolescent, Biologic, vIGA-AD, BSA, Atopic Dermatitis


1. Nutten, S., Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab, 2015. 66 Suppl 1: p. 8-16.

2. AD Langan SM, Irvine AD, Weidinger S. Lancet. 2020 Aug 1;396(10247):345-360.

3. Abuabara, K. International observational atopic dermatitis cohort to follow natural history and treatment course: TARGETDERM AD study design and rational BMJ Open 2020;10:e0399282020.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>